chr19-39307871-C-T
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The ENST00000248668.5(LRFN1):c.2078G>A(p.Gly693Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000267 in 1,534,054 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
ENST00000248668.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
LRFN1 | NM_020862.2 | c.2078G>A | p.Gly693Glu | missense_variant | 5/5 | ENST00000248668.5 | NP_065913.1 | |
LRFN1 | XM_017027033.2 | c.2078G>A | p.Gly693Glu | missense_variant | 5/5 | XP_016882522.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
LRFN1 | ENST00000248668.5 | c.2078G>A | p.Gly693Glu | missense_variant | 5/5 | 1 | NM_020862.2 | ENSP00000248668.4 |
Frequencies
GnomAD3 genomes AF: 0.000125 AC: 19AN: 152188Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000678 AC: 11AN: 162314Hom.: 0 AF XY: 0.0000324 AC XY: 3AN XY: 92452
GnomAD4 exome AF: 0.0000159 AC: 22AN: 1381866Hom.: 1 Cov.: 31 AF XY: 0.0000132 AC XY: 9AN XY: 682426
GnomAD4 genome AF: 0.000125 AC: 19AN: 152188Hom.: 0 Cov.: 32 AF XY: 0.000161 AC XY: 12AN XY: 74362
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 02, 2023 | The c.2078G>A (p.G693E) alteration is located in exon 2 (coding exon 2) of the LRFN1 gene. This alteration results from a G to A substitution at nucleotide position 2078, causing the glycine (G) at amino acid position 693 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at